BOT botanix pharmaceuticals ltd

BOT - Anything but charting, page-15852

  1. 570 Posts.
    lightbulb Created with Sketch. 138
    I’ve been researching the cost structure and breakeven analysis based on gross margin and revenue. Current analyst consensus, while not extensive, even with the cost of debt included, suggests breakeven late 2025 / early 2026. if achieved, that is a “flying start”, and if adoption and growth is set to continue at even a modest relative to current, it stands to reason that 200m+ revenue could be achieved end of 26.

    thoughts?
    Last edited by wilddman: Yesterday, 14:49
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
0.000(0.00%)
Mkt cap ! $578.4M
Open High Low Value Volume
29.5¢ 30.5¢ 28.3¢ $3.185M 10.93M

Buyers (Bids)

No. Vol. Price($)
6 160165 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 166 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.